Pages that link to "Q53396938"

The following pages link to Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. (Q53396938):

Displaying 47 items.

• Radiation and breast cancer: a review of current evidence (Q24797050) (← links)
• Second malignant neoplasms and cardiovascular disease following radiotherapy (Q26864522) (← links)
• Medical factors influencing decision making regarding radiation therapy for breast cancer (Q27005934) (← links)
• Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model (Q28472388) (← links)
• Germline TP53 mutations and Li-Fraumeni syndrome (Q34181585) (← links)
• Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature (Q34294432) (← links)
• Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome (Q34335864) (← links)
• Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes (Q34356721) (← links)
• Prevalence of germline TP53 mutations in HER2+ breast cancer patients (Q34789542) (← links)
• (18)F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome (Q35099349) (← links)
• Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors (Q35117677) (← links)
• Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors (Q35327266) (← links)
• Subsequent malignant neoplasms after hematopoietic cell transplantation (Q35678455) (← links)
• Genetic susceptibility to iatrogenic malignancy (Q36249238) (← links)
• Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes (Q36254710) (← links)
• p53 and disease: when the guardian angel fails (Q36430165) (← links)
• Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management. (Q36493335) (← links)
• Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology (Q36843211) (← links)
• Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology (Q37064189) (← links)
• Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer (Q37299488) (← links)
• Therapy-related myelodysplasia and acute myeloid leukemia (Q37402657) (← links)
• Lack of toxicity in a patient with germline TP53 mutation treated with radiotherapy (Q37719645) (← links)
• Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature. (Q37722958) (← links)
• Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53. (Q37827753) (← links)
• Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors (Q38093037) (← links)
• Li-Fraumeni syndrome: cancer risk assessment and clinical management (Q38197030) (← links)
• TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family (Q41733541) (← links)
• Metachronous medulloblastoma and glioblastoma: Implications for clinical and technical aspects of re-irradiation (Q42199825) (← links)
• Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study (Q43759412) (← links)
• Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation (Q44211368) (← links)
• p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes (Q46665043) (← links)
• Routine TP53 testing for breast cancer under age 30: ready for prime time? (Q47317433) (← links)
• Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? (Q47369258) (← links)
• Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. (Q48690318) (← links)
• Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case. (Q51456575) (← links)
• Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes. (Q55277238) (← links)
• Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma. (Q55287355) (← links)
• Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients (Q57912741) (← links)
• Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations (Q64047862) (← links)
• Hematologic malignancies and Li-Fraumeni syndrome (Q64237936) (← links)
• The Li-Fraumeni syndrome (Q77785199) (← links)
• Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel (Q85247141) (← links)
• Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients (Q85505376) (← links)
• Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience (Q89209769) (← links)
• Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer (Q89572799) (← links)
• Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis (Q90166337) (← links)
• Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53 (Q92758155) (← links)